P
Peter Guarino
Researcher at Yale University
Publications - 42
Citations - 6278
Peter Guarino is an academic researcher from Yale University. The author has contributed to research in topics: Randomized controlled trial & Veterans Affairs. The author has an hindex of 22, co-authored 40 publications receiving 5415 citations. Previous affiliations of Peter Guarino include United States Department of Veterans Affairs & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke
Albert C. Lo,Peter Guarino,Lorie Richards,Jodie K. Haselkorn,George F. Wittenberg,Daniel G. Federman,Daniel G. Federman,Robert J. Ringer,Todd H. Wagner,Hermano Igo Krebs,Bruce T. Volpe,Christopher T. Bever,Dawn M. Bravata,Pamela W. Duncan,Barbara H. Corn,Alysia D. Maffucci,Stephen E. Nadeau,Susan S. Conroy,Janet M. Powell,Grant D. Huang,Peter Peduzzi +20 more
TL;DR: In patients with long-term upper-limb deficits after stroke, robot-assisted therapy did not significantly improve motor function at 12 weeks, as compared with usual care or intensive therapy.
Journal ArticleDOI
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried,Nicholas V. Emanuele,Nicholas V. Emanuele,Jane H. Zhang,Mary Brophy,Todd A. Conner,William C. Duckworth,William C. Duckworth,David J. Leehey,David J. Leehey,Peter A. McCullough,Theresa Z. O'Connor,Paul M. Palevsky,Robert F. Reilly,Stephen L. Seliger,Stuart R. Warren,Suzanne Watnick,Peter Peduzzi,Peter Peduzzi,Peter Guarino +19 more
TL;DR: Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy and safety outcomes included mortality, hyperkalemia, and acute kidney injury.
Journal ArticleDOI
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
Walter N. Kernan,Catherine M. Viscoli,Karen L. Furie,Lawrence H. Young,Silvio E. Inzucchi,Mark Gorman,Peter Guarino,Peter Guarino,Anne M. Lovejoy,Peter Peduzzi,Peter Peduzzi,Robin Conwit,Lawrence M. Brass,Gregory G. Schwartz,Harold P. Adams,L. Berger,Antonio Carolei,Wayne M. Clark,Bruce M. Coull,Gary A. Ford,Dawn Kleindorfer,J. R. O'Leary,Mark W Parsons,Peter A. Ringleb,Souvik Sen,J. D. Spence,David Tanne,David Z. Wang,T. R. Winder +28 more
TL;DR: In this trial involving patients without diabetes who had insulin resistance along with a recent history of ischemic stroke or TIA, the risk of stroke or myocardial infarction was lower among patients who received pioglitazone than among those who received placebo.
Journal ArticleDOI
Million Veteran Program: A mega-biobank to study genetic influences on health and disease.
John Michael Gaziano,John Michael Gaziano,John Concato,Mary Brophy,Mary Brophy,Louis D. Fiore,Louis D. Fiore,Saiju Pyarajan,James Breeling,Stacey B. Whitbourne,Jennifer Deen,Colleen Shannon,Donald E. Humphries,Peter Guarino,Mihaela Aslan,Daniel Anderson,Rene LaFleur,Timothy R. Hammond,Kendra L. Schaa,Jennifer Moser,Grant D. Huang,Sumitra Muralidhar,Ronald M. Przygodzki,Timothy J. O'Leary +23 more
TL;DR: The Million Veteran Program, as an observational cohort study and mega-biobank in the Department of Veterans Affairs (VA) health care system, is designed to contribute to the development of precision medicine.
Journal ArticleDOI
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
Robert Clarke,Jim Halsey,Sarah Lewington,Eva Lonn,Jane Armitage,JoAnn E. Manson,Kaare H. Bønaa,J D Spence,Ottar Nygård,Rex L. Jamison,John Michael Gaziano,Peter Guarino,David L.H. Bennett,F Mir,Richard Peto,Ryan L. Collins +15 more
TL;DR: Dietary supplementation with folic acid to lower homocysteine levels had no significant effects within 5 years on cardiovascular events or on overall cancer or mortality in the populations studied.